Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pamatolol

Known as: (2-(4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl) ethyl)carbamic acid methyl ester, methyl (4-(2-hydroxy-3-(isopropylamino)propoxy)phenylethyl)carbamate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
SummaryThe metabolism of pamatolol was studied in man, dogs, rats and mice after oral administration of a single dose. The drug… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2004
2004
SummaryPrenalterol, previously characterized as a functionally cardioselective partial β-adrenoceptor agonist, was shown to relax… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
2004
2004
SummaryThe effects of atenolol (2–5 mmol/l), sotalol (1–2 mmol/l) and pamatolol (0.1–1 mmol/l), together with N-tertiary butyl… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1982
1982
Hamster adipocyte beta-adrenergic receptors were characterized by the effect on the lipolysis rate of several selective beta… Expand
1982
1982
Prenalterol, previously characterized as a functionally cardioselective partial beta-adrenoceptor agonist, was shown to relax K… Expand
Highly Cited
1981
Highly Cited
1981
The effects of a nonselective (isoproterenol), a beta-1 selective (prenalterol) and a beta-2-selective (procaterol) agonist on… Expand
1979
1979
  • B. Johansson
  • Journal of cardiovascular pharmacology
  • 1979
  • Corpus ID: 10010513
Three β-adrenoceptor antagonists—atenolol (A), metoprolol (M), and pamatolol (P)—were examined with respect to their effects on… Expand
1979
1979
The systemic bioavailability, elimination half‐life (t½), and plasma concentration‐response relationships of pamatolol, a… Expand
1979
1979
  • K. Hoffmann
  • Acta pharmaceutica Suecica
  • 1979
  • Corpus ID: 19805077
Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol 
1978
1978
A Phase I evaluation of a new beta adrenoceptor blocker, pamatolol, was performed in 10 healthy male volunteers, Minor reductions… Expand